Immix Biopharma, Inc. · NASDAQ:IMMX
Hsu Jason received 6,250 Immix Biopharma, Inc. shares as an award (Form 4)
Traded May 22, 2026 · Filed May 29, 2026
On May 22, 2026, Hsu Jason (Director) received 6,250 Immix Biopharma, Inc. shares as an award, leaving 899,250 shares. Filed May 29, 2026 (Form 4).
- Awarded
- 6,250 shares
- Holding after
- 899,250 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 22, 2026 | Common Stock | Award | 6,250 | 899,250 | Direct |
Source
Related
- Immix Biopharma, Inc.
- Hsu Jason
- Immix Biopharma, Inc. shareholders
- Schedule 13G · Eventide Asset Management, LLC · Aug 14, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Aug 13, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Jun 5, 2026
- Form 4 · Ng Carey · May 29, 2026
- Form 4 · Adams Helen C. · May 29, 2026